Applied Clinical Trials
Industry news focusing on the people and organizations who work in the clinical trials profession.
André Choulika
• The newly elected Administrative Council of France Biotech (Paris, France)—the French association for life science entrepreneurs—has appointed André Choulika as the new Chairman, who will succeed the outgoing Chairman Philippe Pouletty who served four terms since 2001 and was not seeking reelection.
Alan Arroyo
• An expansion to Nextrial's (San Ramon, CA) executive team has led to the promotion of Alan Arroyo, who will now serve the company as vice president of global sales and marketing.
Peg Connelly
• A promotion for Peg Connelly will make her the new vice president of clinical operations at Kforce (Tampa, FL), giving her the new task of providing strategic leadership and operational excellence for client alliances.
Kristie Lively
• As the recently appointed vice president of ACORN (Memphis, TN), Kristie Lively will oversee all aspects of the CRO's operations and services.
• Now the Senior Physician at Pfizer (New York, NY) since her appointment as Chief Medical Officer and Senior Vice President, Freda Lewis-Hall, MD, is responsible for enterprise-wide medical, patient safety, regulatory affairs, and quality assurance.
• Expanding its core marketing and business development teams, Health Decisions (Durham, NC) has appointed Ryan Hedspeth as director of marketing, Katie Hendrick as the marketing specialist, and Sean Spollen as e-marketing specialist. Mike Watson will become the director of business development for the East, while David Cerny will hold the same position in the West, Terri Sloan will be the contracts and proposals manager, and Samantha Salvaggio is a new business development associate.
• Omnicare (King of Prussia, PA) has made a series of executive appointments that includes the election of Jeffrey Stamps to senior vice president of pharmacy operations, Beth Kinerk as senior vice president of sales and customer development, and Jonathan Borman as vice president of strategic sourcing.
• Joining RSA (London, UK) as a senior consultant, Roger Anderson, PhD, will be responsible for expanding the executive search component in RSA's Medical Practice and working with the company's global offices on international executive search assignments.
• The vice chairman and chief executive officer of PPD (Wilmington, NC), Fredric Eshelman, has been promoted by the board of directors to the newly created position of executive chairman of the board of directors.
• Mark Shapiro will bring more than 13 years of experience in all phases of preclinical and clinical research management to his new role of director of clinical solutions for Clinipace (Morrisville, NC).
• A promotion from senior vice president of clinical operations to executive vice president of clinical development solutions for inVentiv Clinical (Somerset, NJ) gives Scott Treiber, PhD, the new responsibility of leading the CRO services group and facilitating the interaction between clinical service groups.
• With the appointment of Hal Ward as executive director of global pharmacovigilance, Premiere Research Group (Philadelphia, PA) will have him lead the global pharmacovigilance team to ensure the delivery of quality medical and safety services.
• Joining Azopharma (Hollywood, FL) as the new chief financial officer, Daniel Cammarata will report directly to Phil Meeks, the company's chief executive officer, and will be responsible for overseeing all financial operations for the company and its subsidiaries.
• Genentech (San Francisco, CA) has recently become a supporter of the SNM Clinical Trials Network (Reston, VA)—an initiative that was designed to address the need for streamlined drug discovery through the integration of imaging biomarkers into multicenter clinical trials.
• By selecting ProTrials (Mountain View, CA) to conduct two of its international Phase III clinical trials for novel treatments, Medivation (San Francisco, CA) will depend on the company to test MDV3100 for treating prostate cancer and the investigational drug Dimebon as a treatment for Huntington's disease.
• Collaborating with Pfizer (New York, NY) and the PETACC3 Translational Research Working Party (PTRW), Almac (Craigavon, Ireland) will use its Colorectal Cancer DSA research tool to identify molecular subtypes, biomarkers, and drug targets.
• In an effort to produce a customized, fully Web-enabled Project Portfolio Management System, Quanticate (Cambridge, MA) has entered into a partnership with Atlantic-Global (London, UK).
• The 2008 acquisition of UK-based Matrix Clinical has made it necessary for PharmaLinkFHI (Research Triangle Park, NC) to change its name, which will now be Novella Clinical.
• In acknowledgement of their distinguished and continuing achievements in original research, six members of the American Association for Cancer Research (Philadelphia, PA) have been elected into the National Academy of Sciences.
• To attract and retain world-leading genomics researchers in the province of Ontario, the government is launching the $100 million Global Leadership Round in Genomics and Life Sciences, which will support collaborative research projects that are headquartered in Ontario.
• ERT (Philadelphia, PA) has announced the launch of My Study Portal, an online Web interface that was designed with the purpose of enhancing the accuracy and efficiency of cardiac safety data management in clinical trials.
Wayne Blow publisher of Applied Clinical Trials and Sheryl Walder of ERT enjoy coffee with the crowds at ERT's (Philadelphia, PA) booth at the 45th Annual DIA Meeting held June 22-25 in San Diego, California.
• Headed by veteran Pharmacologist and Clinical Research Executive, Arthur Simon, PhD, the newly established Palm Beach CRO (West Palm Beach, FL), which was created in December of 2008, is an outgrowth of Palm Beach Research Center.
• With a relaunch of its Web site, Phlexglobal (Bucks, UK) hopes to provide clinical trial industry professionals with a comprehensive tool that is easier to navigate and now has added features, including an interactive search tool for jobs and a listing of training courses.
• In an attempt to expand its global footprint, Sparta Systems (Holmdel, NJ) has opened operations in Hong Kong, China.
• Raland Technologies (Rockville, MD) is celebrating 10 years of providing regulatory affairs support and professional services to industry, since being established in 1999.
• With a plan for continuous growth and to create 1000 new jobs in the area, Quintiles (Research Triangle Park, NC) has chosen to remain in Research Triangle Park and open its new world headquarters in Durham, North Carolina.
Quintiles' (Research Triangle Park, NC) new world headquarters located in Durham, North Carolina.
• A new office location in Shanghai is intended to bring Syntagon (Södertälje, Sweden) an expansion that will compliment its existing offices in Sweden and Latvia.
• Relocating its corporate headquarters to Owings Mills in Baltimore City, Maryland, C-TASC will occupy a space more than double the size of its previous facility.
• IXICO (London, England) has opened its new U.S. operations in Chicago, Illinois, which will help facilitate the company's plan to expand its imaging center network and partnership alliance.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.